Ambassador Michael Danagher from the Canadian Embassy in Korea speaks to IVI about global collaboration for COVID-19 vaccine development.

August 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Michael Danagher, Ambassador of Canada to the Koreas, to IVI headquarters today to discuss developments in COVID-19 vaccine research as well as ongoing efforts to sustain programs for long-existing endemic diseases.

From left to right: Francois Belin, Chief Operating Officer of IVI; Jerome Kim, Director General of IVI; H.E. Michael Danagher, Canadian Ambassador to the Koreas; Anh Wartel, Associate Director General of IVI’s EPIC unit.

The delegation from the Canadian Embassy included Ms Alina Kwan, Second Secretary (Political and Economic Affairs), and Mr Paul Choi, Trade Commissioner. Following a general introduction to IVI by Dr Jerome Kim, Director General of IVI, the leadership team provided more in-depth insight into IVI’s major clinical and epidemiological projects across Africa and Asia.